Cencora Inc. (COR)
NYSE
Closed
Oct 6, 2026
Day's Range
311.8352 wk Range
244.82Overview - COR - Cencora Inc.
Key Statistics
Valuation
Enterprise Value
70.81B
P/E (Trailing)
‪22.92‬
P/E (Forward)
‪15.58‬
PEG Ratio
‪2.03‬
Price / Sales (TTM)
‪0.17‬
Price / Book
‪19.33‬
EV / EBITDA
‪12.76‬
Profitability
Gross Margin
‪4.25%‬
Profit Margin
‪0.78%‬
Operating Margin
‪1.41%‬
Return on Assets
‪3.55%‬
Return on Equity
‪96.87%‬
Ownership
Shares Outstanding
190.82M
Float
180.24M
Short % of Shares Outstanding
‪2.57%‬
Held by Insiders
‪4.30%‬
Held by Institutions
‪99.64%‬
Price stats
Beta
‪0.57‬
50-Day Avg
‪317.61‬
200-Day Avg
‪318.39‬
Dividends
Payout Ratio
‪17.45%‬
Frequency
Quarterly
Analyst Consensus
14 analysts
Average price target
‪$ 369.31‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - COR - Cencora Inc.
Peers - COR - Cencora Inc.
Peer Comparison
Compared with companies in Medical Distribution listed on NYSE.
Profile Summary - COR - Cencora Inc.
About
Cencora Inc. is a global pharmaceutical solutions company focused on the sourcing, distribution, and commercialization of medicines and healthcare products. The company supports manufacturers, pharmacies, hospitals, health systems, and other care providers through wholesale distribution, specialty pharmacy services,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
